Titre:
  • Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.
Auteur:Demeestere, Isabelle; Brice, Pauline; Peccatori, Fedro A; Kentos, Alain; Gaillard, I.; Zachée, Pierre; Casasnovas, O.; Van Den Neste, Eric; Dechene, Julie; De Maertelaer, Viviane; Bron, Dominique; Englert, Yvon
Informations sur la publication:Journal of clinical oncology, 31, 7, page (903-909)
Statut de publication:Publié, 2013-03
Sujet CREF:Gynécologie
Cancérologie
MeSH keywords:Adult
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects
Biological Markers -- blood
Drug Therapy, Combination
Estradiol -- blood
Female
Follicle Stimulating Hormone -- blood
Follow-Up Studies
Gonadotropin-Releasing Hormone -- agonists
Hodgkin Disease -- drug therapy
Humans
Luteolytic Agents -- therapeutic use
Lymphoma -- drug therapy
Lymphoma, Non-Hodgkin -- drug therapy
Middle Aged
Norethindrone -- therapeutic use
Premenopause
Primary Ovarian Insufficiency -- blood -- chemically induced -- prevention & control
Prospective Studies
Time Factors
Treatment Failure
Triptorelin Pamoate -- therapeutic use
Note générale:Journal Article
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2012.42.8185
info:pii/JCO.2012.42.8185
info:scp/84875696905
info:pmid/23129737